Patient-reported outcomes (PROs) from JAVELIN Bladder 100: Avelumab
first-line (1L) maintenance plus best supportive care (BSC) vs BSC alone
for advanced urothelial carcinoma (UC)
Patient-reported outcomes (PROs) from JAVELIN Bladder 100: Avelumab first-line (1L) maintenance plus best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma (UC)
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Έτος δημοσίευσης:
2020
Συγγραφείς:
Powles, T. B. Kopyltsov, E. Su, P-J. Parnis, F. X. Park, S. H. Yamamoto, Y. Fong, P. C. Tournigand, C. Duran, M. A. Climent Bamias, A. Caserta, C. Chang, J. Yan, E. and di Pietro, A. Wang, J. Grivas, P.
